BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 38720279)

  • 1. Glycometabolism and lipid metabolism related genes predict the prognosis of endometrial carcinoma and their effects on tumor cells.
    Lin X; Zheng J; Cai X; Liu L; Jiang S; Liu Q; Sun Y
    BMC Cancer; 2024 May; 24(1):571. PubMed ID: 38720279
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel lactylation-related signature to predict prognosis for pancreatic adenocarcinoma.
    Peng T; Sun F; Yang JC; Cai MH; Huai MX; Pan JX; Zhang FY; Xu LM
    World J Gastroenterol; 2024 May; 30(19):2575-2602. PubMed ID: 38817665
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lactate metabolism-related genes to predict the clinical outcome and molecular characteristics of endometrial cancer.
    Shi R; Li H; Wei S; Yu Z; Zhang J; Zhang Q; Zhou T; Yao Y; Zhang Q; Zhang T; Wang H
    BMC Cancer; 2023 May; 23(1):491. PubMed ID: 37259038
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protein-based prognostic signature for predicting the survival and immunotherapeutic efficiency of endometrial carcinoma.
    Lai J; Xu T; Yang H
    BMC Cancer; 2022 Mar; 22(1):325. PubMed ID: 35337291
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MiR-29a-5p inhibits proliferation and invasion and induces apoptosis in endometrial carcinoma via targeting TPX2.
    Jiang T; Sui D; You D; Yao S; Zhang L; Wang Y; Zhao J; Zhang Y
    Cell Cycle; 2018; 17(10):1268-1278. PubMed ID: 29888640
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and validation of a novel lipid metabolism-related gene prognostic signature and candidate drugs for patients with bladder cancer.
    Zhu K; Xiaoqiang L; Deng W; Wang G; Fu B
    Lipids Health Dis; 2021 Oct; 20(1):146. PubMed ID: 34706720
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Construction of an Immune-Autophagy Prognostic Model Based on ssGSEA Immune Scoring Algorithm Analysis and Prognostic Value Exploration of the Immune-Autophagy Gene in Endometrial Carcinoma (EC) Based on Bioinformatics.
    Xu X; Lu F; Fang C; Liu S
    J Healthc Eng; 2022; 2022():7832618. PubMed ID: 35242299
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of a metabolism-related gene expression prognostic model in endometrial carcinoma patients.
    Jiang P; Sun W; Shen N; Huang X; Fu S
    BMC Cancer; 2020 Sep; 20(1):864. PubMed ID: 32894095
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel signature incorporating lipid metabolism- and immune-related genes to predict the prognosis and immune landscape in hepatocellular carcinoma.
    Yang T; Luo Y; Liu J; Liu F; Ma Z; Liu G; Li H; Wen J; Chen C; Zeng X
    Front Oncol; 2023; 13():1182434. PubMed ID: 37346073
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overexpression of TICRR and PPIF confer poor prognosis in endometrial cancer identified by gene co-expression network analysis.
    Yang L; Cui Y; Sun X; Wang Y
    Aging (Albany NY); 2021 Jan; 13(3):4564-4589. PubMed ID: 33495413
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LINC01410/miR-23c/CHD7 functions as a ceRNA network to affect the prognosis of patients with endometrial cancer and strengthen the malignant properties of endometrial cancer cells.
    Lu M; Ding N; Zhuang S; Li Y
    Mol Cell Biochem; 2020 Jun; 469(1-2):9-19. PubMed ID: 32314193
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and Clinical Validation of Novel 8-Gene Prognostic Signature Associated With the Proportion of Regulatory T Cells by Weighted Gene Co-Expression Network Analysis in Uterine Corpus Endometrial Carcinoma.
    Liu J; Geng R; Yang S; Shao F; Zhong Z; Yang M; Ni S; Cai L; Bai J
    Front Immunol; 2021; 12():788431. PubMed ID: 34970268
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Significance of a PTEN Mutational Status-Associated Gene Signature in the Progression and Prognosis of Endometrial Carcinoma.
    Wu Y; Wang J; Ge L; Hu Q
    Oxid Med Cell Longev; 2022; 2022():5130648. PubMed ID: 35251475
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel five-gene metabolism-related risk signature for predicting prognosis and immune infiltration in endometrial cancer: A TCGA data mining.
    Huang H; Cai X; Lin J; Wu Q; Zhang K; Lin Y; Liu B; Lin J
    Comput Biol Med; 2023 Mar; 155():106632. PubMed ID: 36805217
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel signature incorporating genes related to lipid metabolism and immune for prognostic and functional prediction of breast cancer.
    Zhao X; Yan L; Yang Z; Zhang H; Kong L; Zhang N; He Y
    Aging (Albany NY); 2024 May; 16(10):8611-8629. PubMed ID: 38771140
    [TBL] [Abstract][Full Text] [Related]  

  • 16. lncRNA OIP5-AS1 Suppresses Cell Proliferation and Invasion of Endometrial Cancer by Regulating PTEN/AKT via Sponging miR-200c-3p.
    Liu Y; Cai X; Cai Y; Chang Y
    J Immunol Res; 2021; 2021():4861749. PubMed ID: 34368370
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In Silico Establishment and Validation of Novel Lipid Metabolism-Related Gene Signature in Bladder Cancer.
    Sun X; Zhang Y; Chen Y; Xin S; Jin L; Liu X; Zhou Z; Zhang J; Mei W; Zhang B; Yao X; Yang G; Ye L
    Oxid Med Cell Longev; 2022; 2022():3170950. PubMed ID: 35480865
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comprehensive analysis of a novel signature incorporating lipid metabolism and immune-related genes for assessing prognosis and immune landscape in lung adenocarcinoma.
    Wang Y; Xu J; Fang Y; Gu J; Zhao F; Tang Y; Xu R; Zhang B; Wu J; Fang Z; Li Y
    Front Immunol; 2022; 13():950001. PubMed ID: 36091041
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting Thyroid Receptor Interacting Protein 6 by MicroRNA-589-5p Inhibits Cell Proliferation, Migration, and Invasion in Endometrial Carcinoma.
    Wang Y; Dong L; Liu Y
    Cancer Biother Radiopharm; 2019 Oct; 34(8):529-536. PubMed ID: 31424277
    [No Abstract]   [Full Text] [Related]  

  • 20. Lipid metabolism-related gene expression in the immune microenvironment predicts prognostic outcomes in renal cell carcinoma.
    Zhang Q; Lin B; Chen H; Ye Y; Huang Y; Chen Z; Li J
    Front Immunol; 2023; 14():1324205. PubMed ID: 38090559
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.